Speciality: Hematology
Description:
Anemia is a common condition, but its signs can be subtle and easy to overlook. In adults, some of the key symptoms include persistent fatigue, weakness, and shortness of breath, even with routine activities. You may also notice pale or yellowish skin, irregular heartbeats, or headaches. Cold hands and feet, dizziness, and chest pain can also indicate low hemoglobin levels. If you experience these symptoms consistently, it’s important to consult a healthcare professional for a proper diagnosis. Early recognition of anemia can help prevent complications and ensure effective treatment. Remember, many causes of anemia are treatable once identified. Stay alert to these signs and take proactive steps for your health.
See More Webinars @ Hidoc Webinars
1.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
2.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
3.
Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers
4.
Adjuvant Combination for Kidney Cancer Gets FDA's Blessing
5.
TKI Discontinuation Feasible After ALL Treatment
1.
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer
2.
Importance of Early Detection in Hematology
3.
Reproductive Hormones and Immune Cell Metabolism: Mechanisms, Clinical Implications, and Emerging Evidence
4.
Clonal Hematopoiesis as a Mechanism of Age-Related Disease
5.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Expert Perspectives on Hematology
5.
Screening for Red Cell Membrane Disorders Through Ektacytometry-Based Deformability Profiling
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation